• 1328 Citations
  • 15 h-Index
19982019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where G. Ostoros is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Efficacy and safety of the biosimilar ABP 215 compared with bevacizumab in patients with advanced nonsquamous non–small cell lung cancer (MAPLE): A randomized, double-blind, phase III study

Thatcher, N., Goldschmidt, J. H., Thomas, M., Schenker, M., Pan, Z., Rodriguez, L. P. A., Breder, V., Ostoros, G. & Hanes, V., Apr 1 2019, In : Clinical Cancer Research. 25, 7, p. 2088-2095 8 p.

Research output: Contribution to journalArticle

Open Access
  • 6 Citations (Scopus)

    Erratum: Efficacy and safety of the biosimilar ABP 215 compared with bevacizumab in patients with advanced nonsquamous non–small cell lung cancer (MAPLE): A randomized, double-blind, phase III study (Clin Cancer Res (2019) 25(2088–95)Doi:10.1158/1078-0432.CCR-18-2702)

    Thatcher, N., Goldschmidt, J. H., Thomas, M., Schenker, M., Pan, Z., Paz-Ares Rodriguez, L., Breder, V., Ostoros, G. & Hanes, V., Jan 1 2019, In : Clinical Cancer Research. 25, 10, 1 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • KRAS mutations predict response and outcome in advanced lung adenocarcinoma patients receiving first-line bevacizumab and platinum-based chemotherapy

    Ghimessy, A. K., Gellert, A., Schlegl, E., Hegedus, B., Raso, E., Barbai, T., Timar, J., Ostoros, G., Megyesfalvi, Z., Gieszer, B., Moldvay, J., Renyi-Vamos, F., Lohinai, Z., Hoda, M. A., Klikovits, T., Klepetko, W., Laszlo, V. & Dome, B., Oct 2019, In : Cancers. 11, 10, 1514.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Citation (Scopus)